Combined anticancer therapy with imidazoacridinone analogue C‐1305 and paclitaxel in human lung and colon cancer xenografts—Modulation of tumour angiogenesis
Marta Świtalska(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy), Joanna Wietrzyk(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy), Adrianna Moszyńska(Gdańsk Medical University), Rafał Bartoszewski(University of Wrocław), Magdalena Milczarek(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy), Mateusz Psurski(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy), Maciej Bagiński(Gdańsk University of Technology), Karol Krzymiński(University of Gdańsk), Beata Filip‐Psurska(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy), Małgorzata Gawrońska(University of Gdańsk), Aleksandra Dąbrowska(University of Gdańsk)
Cited by 12
Related Papers
Comprehensive review of antimicrobial activities of plant flavonoids
|Phytochemistry Reviews|2018|1.2k
miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target
|Angiogenesis|2018|291
Somatic mosaicism for copy number variation in differentiated human tissues
|Human Mutation|2008|214
Primary endothelial cell–specific regulation of hypoxia‐inducible factor (HIF)‐1 and HIF‐2 and their target gene expression profiles during hypoxia
|The FASEB Journal|2019|212
A Synonymous Single Nucleotide Polymorphism in ΔF508 CFTR Alters the Secondary Structure of the mRNA and the Expression of the Mutant Protein
|Journal of Biological Chemistry|2010|200